Naheed is the President of Recursion Canada, the Canadian wholly-owned subsidiary of Recursion Pharmaceuticals (NASDAQ: RXRX). Prior to joining Recursion, Naheed was the Co-founder, President and CEO of Cyclica, a Toronto-based biotech company (acquired by Recursion in May 2023). At Cyclica, Naheed had the distinct privilege of working with an incredibly talented and dedicated team that was considered one of the pioneers of what is now the increasingly hot space of AI for Drug Discovery and Development. Naheed is also a co-founder and Board Member of EntheogeniX Biosciences, a psychedelic inspired biotech company for mental health, co-founder of the Alliance for Artificial Intelligence in Healthcare (AAIH) for which he served as Chair until May 2023, Board Member of the Ontario Bioscience Innovation Organization (OBIO), and Member of the Life Sciences Advisory Group for Global Affairs Canada. Naheed is passionate about how people interact with technology to inform effective decision making, while dedicated to advancing the responsible application of AI to healthcare and the impact on patients. Naheed holds an MBA from Rotman School of Business and an undergraduate degree from the University of Ottawa.